Alcohol, genetics and risk of breast cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
Catherine A. McCarty(University of Minnesota, Duluth), Regina G. Ziegler(National Institutes of Health), Craig Williams(The University of Adelaide), Meredith Yeager(Frederick National Laboratory for Cancer Research), Douglas J. Reding(Ascension), John Commins(National Institutes of Health), James K. Burmester(Marshfield Clinic), Catherine Schairer(National Cancer Institute)
Cited by 23
Related Papers
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
|Nature Genetics|2007|1.5k
Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data
|Nature Biotechnology|2013|1.1k
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
|Nature Genetics|2007|1.1k
Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
|JNCI Journal of the National Cancer Institute|2012|1.1k